Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Axsome Therapeutics shares jumped about 14% after the U.S. Food and Drug Administration approved AUVELITY for the treatment of agitation associated with dementia due to Alzheimer’s disease. The decision extends AUVELITY's label beyond major depressive disorder and is supported by positive Phase 3 results from ADVANCE-1 and ACCORD-2.
Joseph R. Robinson, a member of the board of directors at WesBanco, Inc. (NASDAQ: WSBC), has increased his position in the company through recent share acquisitions. According to an amended Form 4 filing submitted to the SEC, Mr. Robinson purchased a total of 1,000 shares on April 27, 2026. This transaction, which totaled $34,512, was executed via …
Diageo shares climbed 4% after President Donald Trump said he will remove tariffs and restrictions related to whiskey trade between Scotland and Kentucky. The announcement, made following a visit to the White House by the King and Queen of the United Kingdom, cited longstanding trade issues - including matters tied to wooden barrels - and credited …
Zenas BioPharma is a high-conviction long because management has secured new financing, is preparing a BLA filing for obexelimab, and expects Phase 2 lupus data by year-end 2026. The market has punished the stock after a disappointing IgG4-RD Phase 3 readout, leaving upside if obexelimab shows meaningful activity in SLE or if the FDA engagement aro…
Roger E. Susi, who serves as the CEO, President, and Chairman of IRADIMED CORP (NASDAQ:IRMD), has completed an indirect sale of common stock totaling $657,709. The transactions were conducted through a trust and took place over two days in late April 2026.The disposal involved the sale of 7,500 shares of IRADIMED common stock by the Phillip Susi 20…
On April 30, U.S. President Donald Trump publicly congratulated Ali al-Zaidi following his nomination by Iraq’s Coordination Framework as their candidate for prime minister. Trump expressed optimism about a productive bilateral relationship and urged the formation of a government free from terrorism. The announcement comes after an earlier January …
The U.S. Department of the Treasury's Office of Foreign Assets Control has announced sanctions on former Democratic Republic of the Congo president Joseph Kabange Kabila for his role in supporting armed groups seeking to overthrow the current DRC government. The measures target Kabila's ties to the March 23 Movement (M23) and the Congo River Allian…
Nazar M. Khan, serving as the Chief Technology Officer and a director at Terawulf Inc. (NASDAQ: WULF), has completed a series of stock transactions according to recent SEC Form 4 filings. The activity, reported on April 24, 2026, involved the acquisition of shares through the vesting of performance stock units followed by a sale of a portion of tho…
A group of significant stakeholders in Stratus Properties Inc (NASDAQ: STRS), including Oasis Management Co Ltd., Oasis Investments II Master Fund Ltd., and Seth Fischer, have reported the sale of common stock totaling $313,791. The divestment occurred through two distinct transaction windows in April 2026, involving a total of 10,493 shares. These…
Nuvalent is a clinical-stage precision oncology company with two lead kinase programs that have near-term regulatory and pivotal catalysts in 2026. The stock trades at about $99.35 with a market cap near $7.85B and roughly $2.87B in cash on the balance sheet. This trade idea is a directional long into upcoming FDA decisions and program readouts, wi…
A recent regulatory filing has revealed that Kenneth Thomas Warriner, a director at Meridian Corp (NASDAQ: MRBK), has increased his position in the company's common stock. The transaction occurred on April 30, 2026, reflecting an acquisition of 1,000 shares at a price point of $18.415 per share. This purchase, totaling $18,415, brings Mr. Warriner'…
Kinetic, a fiber internet provider and business unit of Uniti Group (NASDAQ: UNIT), announces a new bundled offer that provides eligible customers with a $10 monthly discount on YouTube TV when paired with Kinetic's high-speed fiber internet. This bundle enhances Kinetic's service value by combining fast and reliable broadband with flexible, multi-…
Gentex Corp (NASDAQ:GNTX) director Richard O. Schaum completed a series of stock transactions on April 30, 2026, involving both the acquisition of shares through options and a subsequent sale of common stock. These movements occurred against a backdrop of recent financial performance where the company outperformed market expectations for its first-…
Goldman Sachs argues that South Africa's fiscal results for the 2025/26 year — highlighted by March budget data showing revenue ahead of prior estimates and expenditures in line — increase the likelihood of positive credit actions from major agencies. The bank expects upgrades from the current BB median toward BB+ over the next year and flags immin…
UPS is increasing its presence in the prescription drug delivery market as part of a multi-year turnaround, and CEO Carol Tome said the company expects that push to deliver results in the second half of the year. Healthcare shipments, which include temperature-controlled and radioactive medicines, offer higher margins and greater resilience to econ…
An insider transaction at Auburn National Bancorporation, Inc. (NASDAQ: AUBN) has been recorded following a purchase by one of the company's directors. Conn Walton T Jr., serving as a director for the institution, acquired a total of 350 shares of common stock on April 30, 2026. The transaction, which totaled $8,363, was completed through two disti…
Axsome Therapeutics announced FDA approval of AUVELITY (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with dementia due to Alzheimer's disease. This first-in-class medication targets NMDA and sigma-1 receptors, addressing a significant unmet medical need for Alzheimer's patients and their caregivers. Clinical tri…
Meta beat Q1 expectations with 33% revenue growth to $56.31B and sharply higher EPS, yet shares plunged after management raised 2026 capex to $125-145B. That capex is largely AI infrastructure spending that should expand long-term TAM and protect margins vs. competitors. This trade idea buys the selloff with a clear entry, stop and target aligned t…
Daniel J. Leonard, a member of the board of directors at Oak Valley Bancorp (NASDAQ: OVLY), has executed a purchase of common stock in the company. The transaction took place on April 29, 2026, involving an acquisition of 375 shares. This buy order was completed at a price point of $33.00 per share, resulting in a total investment value of $12,375.…
Stocks across market-cap tiers moved sharply Thursday as company-specific headlines and earnings flows drove notable winners and losers. Mega-cap pharmaceuticals and industrials logged double-digit gains, some large-cap technology names climbed while others fell, and several mid- and small-cap issues experienced outsized rallies or steep declines.
Kadant Inc. announced it will release its first quarter 2026 financial results after market close on May 5, 2026, followed by a webcast and earnings call on May 6. The company will discuss its financial performance and future expectations during the call. Kadant is a global supplier of industrial processing technologies and operates worldwide.
Markets will be closely watching a concentrated set of manufacturing indicators and weekly positioning reports on Friday, May 1, 2026. Headlining the calendar are the May Manufacturing PMI and the ISM Manufacturing PMI, along with ISM subcomponents that gauge price pressures and employment trends. A sequence of weekly energy and commodity position …
Since President Donald Trump resumed office in January 2025, the U.S. Supreme Court has heard and decided a wide array of cases testing the scope of executive authority across trade, immigration, federal agency governance, military deployments, civil rights and federal workforce actions. Several rulings have already constrained elements of the admi…
Toll Brothers, Inc., a leading US luxury home builder, announced the grand opening of its new residential community, Toll Brothers at Oakhill Reserve, in Tomball, Texas. Featuring modern single-family homes with high-end amenities and located in a top-rated school district, the community targets families seeking luxury and convenience. This expansi…
Cullinan Therapeutics is a clinical-stage oncology and immuno-oncology company trading at roughly $790M market value while sitting on a large cash position. Positive pivotal data in its zipalertinib program and multiple clinical readouts set up a potential 2027 FDA catalyst. For traders willing to accept clinical binary risk, a mid-term long (45 tr…
